12/120
0.5 / 5 stars
All 120 Win/Lose results shown below
IMNN Roast Me summary
Imunon, Inc. (IMNN). Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
Trailing 1 year (4 quarters): 0 wins, 12 lossesLast fetched: 25 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseIMNN / S&P -39.46% / 15.20% |
LoseIMNN / S&P IMNN unavailable / 15.00% |
LoseIMNN / S&P IMNN unavailable / 50.40% |
| 2026-Q10/3 |
LoseIMNN / S&P -22.83% / -4.33% |
LoseIMNN / S&P IMNN unavailable / 11.30% |
LoseIMNN / S&P IMNN unavailable / 27.70% |
| 2025-Q40/3 |
LoseIMNN / S&P -25.73% / 2.65% |
LoseIMNN / S&P IMNN unavailable / 9.00% |
LoseIMNN / S&P IMNN unavailable / 13.40% |
| 2025-Q30/3 |
LoseIMNN / S&P -50.84% / 8.12% |
LoseIMNN / S&P IMNN unavailable / 4.61% |
LoseIMNN / S&P IMNN unavailable / 13.45% |
| 2025-Q20/3 |
LoseIMNN / S&P -23.81% / 10.94% |
LoseIMNN / S&P IMNN unavailable / 4.83% |
LoseIMNN / S&P IMNN unavailable / 10.63% |
| 2025-Q11/3 |
WinIMNN / S&P 10.53% / -4.27% |
LoseIMNN / S&P IMNN unavailable / 4.98% |
LoseIMNN / S&P IMNN unavailable / 10.57% |
| 2024-Q40/3 |
LoseIMNN / S&P -10.38% / 2.41% |
LoseIMNN / S&P IMNN unavailable / 5.25% |
LoseIMNN / S&P IMNN unavailable / 6.15% |
| 2024-Q30/3 |
LoseIMNN / S&P -8.62% / 5.89% |
LoseIMNN / S&P IMNN unavailable / 5.89% |
LoseIMNN / S&P IMNN unavailable / 6.11% |
| 2024-Q20/3 |
LoseIMNN / S&P -29.27% / 4.28% |
LoseIMNN / S&P IMNN unavailable / 5.38% |
LoseIMNN / S&P IMNN unavailable / 5.12% |
| 2024-Q11/3 |
WinIMNN / S&P 141.18% / 10.56% |
LoseIMNN / S&P IMNN unavailable / 5.71% |
LoseIMNN / S&P IMNN unavailable / 5.59% |
| 2023-Q40/3 |
LoseIMNN / S&P -30.61% / 11.69% |
LoseIMNN / S&P IMNN unavailable / 6.81% |
LoseIMNN / S&P IMNN unavailable / 7.78% |
| 2023-Q30/3 |
LoseIMNN / S&P -24.03% / -3.27% |
LoseIMNN / S&P IMNN unavailable / 7.52% |
LoseIMNN / S&P IMNN unavailable / -5.03% |
| 2023-Q20/3 |
LoseIMNN / S&P 4.03% / 8.74% |
LoseIMNN / S&P IMNN unavailable / 9.50% |
LoseIMNN / S&P IMNN unavailable / -8.57% |
| 2023-Q10/3 |
LoseIMNN / S&P -8.15% / 7.50% |
LoseIMNN / S&P IMNN unavailable / 10.77% |
LoseIMNN / S&P IMNN unavailable / -15.69% |
| 2022-Q40/3 |
LoseIMNN / S&P -19.64% / 7.56% |
LoseIMNN / S&P 0.00% / 11.88% |
LoseIMNN / S&P IMNN unavailable / -17.99% |
| 2022-Q30/3 |
LoseIMNN / S&P -8.70% / -4.88% |
LoseIMNN / S&P 0.00% / 13.47% |
LoseIMNN / S&P IMNN unavailable / -1.41% |
| 2022-Q20/3 |
LoseIMNN / S&P -63.64% / -16.10% |
LoseIMNN / S&P 0.00% / 13.71% |
LoseIMNN / S&P IMNN unavailable / 11.04% |
| 2022-Q10/3 |
LoseIMNN / S&P -37.53% / -4.60% |
LoseIMNN / S&P 0.00% / 15.97% |
LoseIMNN / S&P IMNN unavailable / 42.23% |
| 2021-Q40/3 |
LoseIMNN / S&P -41.30% / 11.03% |
LoseIMNN / S&P 0.00% / 15.00% |
LoseIMNN / S&P IMNN unavailable / 96.40% |
| 2021-Q30/3 |
LoseIMNN / S&P -27.56% / 0.58% |
LoseIMNN / S&P 0.00% / 10.77% |
LoseIMNN / S&P IMNN unavailable / 69.42% |
| 2021-Q20/3 |
LoseIMNN / S&P -7.97% / 8.55% |
LoseIMNN / S&P 0.00% / 6.58% |
LoseIMNN / S&P IMNN unavailable / 51.81% |
| 2021-Q12/3 |
WinIMNN / S&P 94.37% / 6.17% |
WinIMNN / S&P 0.00% / -1.06% |
LoseIMNN / S&P IMNN unavailable / 7.39% |
| 2020-Q41/3 |
LoseIMNN / S&P -2.74% / 12.15% |
WinIMNN / S&P 0.00% / -3.72% |
LoseIMNN / S&P IMNN unavailable / -33.42% |
| 2020-Q31/3 |
LoseIMNN / S&P -80.38% / 8.93% |
WinIMNN / S&P 0.00% / -2.04% |
LoseIMNN / S&P IMNN unavailable / -27.10% |
| 2020-Q22/3 |
WinIMNN / S&P 313.33% / 20.54% |
WinIMNN / S&P 0.00% / -0.46% |
LoseIMNN / S&P IMNN unavailable / -27.11% |
| 2020-Q10/3 |
LoseIMNN / S&P -47.37% / -19.60% |
LoseIMNN / S&P 0.00% / 3.47% |
LoseIMNN / S&P IMNN unavailable / -14.75% |
| 2019-Q41/3 |
WinIMNN / S&P 11.04% / 9.07% |
LoseIMNN / S&P 0.00% / 5.36% |
LoseIMNN / S&P IMNN unavailable / 2.99% |
| 2019-Q30/3 |
LoseIMNN / S&P -15.38% / 1.70% |
LoseIMNN / S&P 0.00% / 5.02% |
LoseIMNN / S&P IMNN unavailable / 0.21% |
| 2019-Q20/3 |
LoseIMNN / S&P -7.14% / 4.30% |
LoseIMNN / S&P 0.00% / 6.64% |
LoseIMNN / S&P IMNN unavailable / 8.65% |
| 2019-Q11/3 |
WinIMNN / S&P 39.01% / 13.65% |
LoseIMNN / S&P 0.00% / 8.12% |
LoseIMNN / S&P IMNN unavailable / 14.29% |
| 2018-Q40/3 |
LoseIMNN / S&P -49.10% / -13.52% |
LoseIMNN / S&P 0.00% / 9.05% |
LoseIMNN / S&P IMNN unavailable / 18.23% |
| 2018-Q30/3 |
LoseIMNN / S&P -6.10% / 7.71% |
LoseIMNN / S&P IMNN unavailable / 10.21% |
LoseIMNN / S&P IMNN unavailable / 19.06% |
| 2018-Q21/3 |
WinIMNN / S&P 31.70% / 3.43% |
LoseIMNN / S&P IMNN unavailable / 9.03% |
LoseIMNN / S&P IMNN unavailable / 14.46% |
| 2018-Q10/3 |
LoseIMNN / S&P -16.42% / -0.76% |
LoseIMNN / S&P IMNN unavailable / 7.68% |
LoseIMNN / S&P IMNN unavailable / 12.46% |
| 2017-Q41/3 |
WinIMNN / S&P 78.67% / 6.64% |
LoseIMNN / S&P IMNN unavailable / 7.03% |
LoseIMNN / S&P IMNN unavailable / 13.82% |
| 2017-Q30/3 |
LoseIMNN / S&P -26.83% / 4.48% |
LoseIMNN / S&P IMNN unavailable / 5.68% |
LoseIMNN / S&P IMNN unavailable / 17.57% |
| 2017-Q20/3 |
LoseIMNN / S&P -49.51% / 3.09% |
LoseIMNN / S&P IMNN unavailable / 4.83% |
LoseIMNN / S&P IMNN unavailable / 17.74% |
| 2017-Q10/3 |
LoseIMNN / S&P -3.33% / 6.07% |
LoseIMNN / S&P IMNN unavailable / 3.67% |
LoseIMNN / S&P IMNN unavailable / 13.32% |
| 2016-Q40/3 |
LoseIMNN / S&P -75.41% / 3.82% |
LoseIMNN / S&P IMNN unavailable / 2.09% |
LoseIMNN / S&P IMNN unavailable / 7.05% |
| 2016-Q30/3 |
LoseIMNN / S&P -3.94% / 3.85% |
LoseIMNN / S&P IMNN unavailable / 0.20% |
LoseIMNN / S&P IMNN unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-28
| Metric | IMNN total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -73.77% | 20.78% |
| Annualized return | -73.77% | 20.78% |
5Y · 2021-09-01 to 2026-08-28
| Metric | IMNN total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -99.23% | 83.14% |
| Annualized return | -62.20% | 12.86% |
10Y · 2016-09-01 to 2026-08-28
| Metric | IMNN total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -99.95% | 319.30% |
| Annualized return | -53.57% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-25.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |